SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOREA, Pier Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.317
EU - Europa 13.428
AS - Asia 10.851
SA - Sud America 817
AF - Africa 86
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 26
Totale 62.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.178
CN - Cina 4.339
SG - Singapore 3.719
UA - Ucraina 3.039
IT - Italia 2.962
DE - Germania 2.951
TR - Turchia 2.210
GB - Regno Unito 1.279
SE - Svezia 1.053
FI - Finlandia 817
BR - Brasile 720
RU - Federazione Russa 299
PL - Polonia 260
FR - Francia 220
HK - Hong Kong 175
NL - Olanda 146
BE - Belgio 137
CA - Canada 109
ID - Indonesia 86
CZ - Repubblica Ceca 68
VN - Vietnam 56
LT - Lituania 47
IN - India 46
ZA - Sudafrica 45
IR - Iran 33
AR - Argentina 31
AT - Austria 27
IQ - Iraq 25
ES - Italia 23
AU - Australia 22
EU - Europa 21
BD - Bangladesh 20
EC - Ecuador 20
CL - Cile 17
PK - Pakistan 17
IE - Irlanda 16
JP - Giappone 16
KR - Corea 15
RO - Romania 15
MX - Messico 13
MA - Marocco 11
UZ - Uzbekistan 11
CO - Colombia 10
IL - Israele 10
PT - Portogallo 9
VE - Venezuela 9
JO - Giordania 8
NO - Norvegia 8
TW - Taiwan 8
BG - Bulgaria 7
TN - Tunisia 7
CH - Svizzera 6
EG - Egitto 6
NP - Nepal 6
PS - Palestinian Territory 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
GR - Grecia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
AL - Albania 4
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
IM - Isola di Man 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
LV - Lettonia 3
MO - Macao, regione amministrativa speciale della Cina 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
Totale 62.538
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.579
Fairfield 3.672
Jacksonville 3.290
Chandler 2.908
Houston 2.826
Ann Arbor 2.404
Ashburn 2.077
Santa Clara 1.963
Singapore 1.726
Wilmington 1.651
Seattle 1.514
Cambridge 1.157
Izmir 1.118
Nanjing 1.015
Beijing 714
Princeton 711
Boardman 520
Ferrara 440
Milan 387
San Diego 344
Nanchang 323
Shenyang 303
Shanghai 302
Los Angeles 267
Warsaw 236
Hebei 204
Dearborn 203
Helsinki 187
Bremen 182
San Mateo 176
Changsha 174
Falkenstein 173
Tianjin 173
Hong Kong 172
Addison 170
Jiaxing 167
New York 164
Brussels 134
Jinan 120
Falls Church 115
Zhengzhou 103
London 100
Kunming 96
Auburn Hills 94
Norwalk 92
Mountain View 85
Jakarta 81
Rome 81
Ningbo 78
Munich 71
Philadelphia 70
Guangzhou 66
Florence 64
Orange 63
Redwood City 63
Düsseldorf 61
Verona 57
Frankfurt am Main 54
Toronto 54
Bologna 53
Des Moines 51
São Paulo 47
Dong Ket 46
Washington 44
Augusta 40
Lanzhou 39
Taizhou 39
Amsterdam 37
Brno 37
Indiana 37
Tappahannock 36
Ottawa 33
Chicago 30
Hangzhou 28
Council Bluffs 27
Redmond 27
The Dalles 27
Bari 24
Haikou 24
Naples 24
Torino 23
Hefei 22
Olomouc 22
Ardabil 21
Rio de Janeiro 21
Kilburn 20
Napoli 20
Belo Horizonte 19
Nuremberg 18
Brasília 17
Camerino 17
Catania 16
Leawood 16
Padova 16
San Francisco 15
Cagliari 13
Changchun 13
Espoo 13
Turin 13
Baghdad 12
Totale 41.491
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.206
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 367
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 289
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 269
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 215
A glance at adenosine receptors: Novel target for antitumor therapy 212
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 208
Pharmacology of Adenosine Receptors: The State of the Art 187
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 179
The A3 adenosine receptor: history and perspectives 179
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 176
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 171
Recettori e trasduzione del segnale 170
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 170
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 164
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 164
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 163
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 162
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 162
Adenosine receptors and human melanoma 161
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 158
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 157
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 157
Recettori e trasduzione del segnale 156
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 155
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 154
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 154
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 154
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 153
Pathological overproduction: the bad side of adenosine 153
Current status of A1 adenosine receptor allosteric enhancers 152
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 152
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 151
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 150
Adenosine receptor targeting in health and disease 150
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 149
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 149
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 149
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 148
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 148
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 148
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 147
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 145
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 145
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 145
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 145
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 144
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 144
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 143
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 142
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. 142
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 142
Ala scan analogues of HOE 140. Synthesis and biological activities 141
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 141
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 140
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 140
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 140
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 140
Therapeutic potential of adenosine receptor antagonists and agonists 140
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 139
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 138
Adenosine receptors and cancer 138
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 138
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 138
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues 137
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 136
Adenosine receptors in health and disease 136
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 136
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 136
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 135
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 135
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 134
Adenosine signaling contributes to ethanol-induced fatty liver in mice 134
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 134
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 133
Temperature dependence of [3H]PAF binding to washed human platelets 133
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 133
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 133
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 132
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 132
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 131
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 131
Agonists and antagonists: Molecular mechanisms and therapeutic applications 131
Binding thermodynamics at A1 and A2A adenosine receptors 130
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 130
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 130
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 130
van't Hoff Based Thermodynamics 130
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 129
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 129
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 129
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 129
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 128
Rm and logP values of 5-nitroimidazoles 127
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 127
New potent and selective human adenosine A3 receptor antagonists. 127
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 126
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 126
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 126
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 126
Totale 16.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 296.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.424
Totale 307.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.963 0 0 0 0 0 0 0 0 0 1.296 499 168
2020/20217.905 757 776 288 923 354 860 233 937 154 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/20259.485 395 383 1.062 633 1.646 1.192 406 904 1.847 1.017 0 0
Totale 63.190